Event JSON
{
"id": "f1c95317a949cd726565c87e24bc13d12fb40c4efe2afca1a43ee014ca985645",
"pubkey": "ecc0938ff22f9bb1560ffc6b642a0ef411c0a96012d3d7356fbd2c2340b4518e",
"created_at": 1722420092,
"kind": 1,
"tags": [
[
"proxy",
"https://mas.to/@kakape/112880523206884394",
"web"
],
[
"proxy",
"https://mas.to/users/kakape/statuses/112880523206884394",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://mas.to/users/kakape/statuses/112880523206884394",
"pink.momostr"
],
[
"-"
]
],
"content": "Some view the result as a game-changer. “Imagine if you had a vaccine that was 100% effective in cisgender women, and you needed a booster every 6 months,” says Chris Beyrer, an epidemiologist who runs the Duke Global Health Institute. “You would be saying, ‘That’s it, we finally have a tool that can end this epidemic.’”\n\nhttps://www.science.org/content/article/landmark-trial-may-herald-new-era-hiv-prevention",
"sig": "4f669b7d31952ec3a233f72e1c845b862607a3709f398ef04a453060d4550d5f239c002b8055ee9730f6e8e27739999459d0c3aaff8af8bf0ab1084c6be5d9ad"
}